92 reports

  • 6.6 OTHER BRANDED DIRECT-ACTING ANTIVIRALS
  • 7.2 REDUCING THE OVERALL COST BURDEN OF DIRECT-ACTING ANTIVIRAL TREATMENT

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025 Summary Hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic infections of the liver and, if left untreated, can result in fibrosis, permanent liver damage (cirrhosis), Hepatocellular...

  • Antiviral
  • Market Size
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.
  • Global Hepatitis B Treatment - Drug Pipeline
  • Global Hepatitis B Treatment - Drug Pipeline

Top ## players hold majority of stake in the market ##.

  • Antiviral
  • World
  • Market Size
  • AbbVie Inc.
  • Bristol-Myers Squibb Company

Antiviral Drugs - Global Market Outlook (2016-2022) ## Executive Summary ## Preface ##. ## Abstract ##. ## Stake Holders ##. ## Research Scope ##. ## Research Methodology ##. ##. ## Data Mining ##. ##. ## Data Analysis ##. ##. ## Data Validation ##. ##. ## Research Approach ##. ## Research Sources ##. ##. ## Primary Research Sourc

  • Antiviral
  • APAC
  • North America
  • World
  • Market Size
  • 6.3 GILEAD

HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus...

  • Antiviral
  • World
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

This influence varies from one industry to another, but also from one period of time to another.

  • Antiviral
  • Therapy
  • World
  • Demand
  • ANTIVIRAL EFFICACY OF HEPSERA IN HBEAG-POSITIVE PATIENTS
  • ANTIVIRAL EFFICACY OF BARACLUDE COMPARED WITH EPIVIR-HBV

Hepatitis B Virus (HBV) Therapeutics - US Drug Forecast and Market Analysis to 2024 Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains...

  • Antiviral
  • United States
  • World
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.

Segments Covered ##) Global Antiviral Drugs Market a.

  • Antiviral
  • APAC
  • United States
  • World
  • Demand
  • ANTIVIRAL EFFICACY OF BARACLUDE IN EPIVIR-HBV-REFRACTORY PATIENTS
  • ANTIVIRAL EFFICACY OF HEPSERA IN HBEAG-POSITIVE PATIENTS

Hepatitis B Virus (HBV) Therapeutics - China Drug Forecast and Market Analysis to 2024 Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains...

  • Antiviral
  • China
  • World
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.
  • ANTIVIRAL EFFICACY OF BARACLUDE IN EPIVIR-HBV-REFRACTORY PATIENTS
  • ANTIVIRAL EFFICACY OF HEPSERA IN HBEAG-POSITIVE PATIENTS

Hepatitis B Virus (HBV) Therapeutics - Japan Drug Forecast and Market Analysis to 2024 Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains...

  • Antiviral
  • Japan
  • World
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.

Hepatitis C Therapies Market 2017-2027 ##.

  • Antiviral
  • Hepatitis Treatment
  • Forecast
  • Market Shares
  • Market Size
  • ANTIVIRAL DRUGS MARKET IN EMEA
  • MARKET SIZE AND FORECAST

About Antiviral Drugs Antiviral drugs are agents used to cure a viral infection by inhibiting the growth of viral pathogens. There are two types of antiviral agents which includes narrow-spectrum antiviral agents and broad-spectrum antiviral agents. Technavio’s analysts forecast the global antiviral drugs market to grow...

  • Antiviral
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • ViiV Healthcare Ltd.
  • SHARE OF INFECTIOUS DISEASES MARKET IN PHARMACEUTICAL MARKET IN CHINA 2015
  • HIGHLIGHTS

It blocks IL-## receptor signaling and prevents the binding of IL-##alpha and IL-## beta to the IL-## receptor.

  • Antiviral
  • China
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • TREATMENT ACCESS
  • 6.6 CHINA

ANTIVIRAL ACTIVITY OF APRICITABINE IN TREATMENT-EXPERIENCED HIV-##-INFECTED PATIENTS WITH M##V WHO ARE FAILING COMBINATION THERAPY.

  • Antiviral
  • East Asia
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • ViiV Healthcare Ltd.

Interferon and Antiviral ##. ##. ##. ##.

  • Antiviral
  • Hepatitis Treatment
  • Therapy
  • World
  • Market Size

According to the WHO, cases of viral infections increase by more than ## million each year with around ## million patients already suffering from one of the four Sexually Transmitted Infections (STIs), such as Acquired Immunodeficiency Syndrome (AIDS).

  • Antiviral
  • Therapy
  • United States
  • Forecast
  • BUSINESS SEGMENTATION BY REVENUE
  • GILEAD SCIENCES

It has also signed a contract worth $## billion with Modern Pharmaceuticals for its messenger RNA therapeutics platform for developing new antiviral vaccines and passive immunity therapies.

  • Antiviral
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.

(USA) ##.

  • Anti-Infective
  • Antiviral
  • Hepatitis
  • World
  • Market Shares

The company has also signed a deal worth $## billion with Moderna for its messenger RNA therapeutics platform in developing new antiviral vaccines and passive immunity therapies.

  • Antiviral
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson

Hepatitis C

4546 5000 3864
  • DIRECT-ACTING ANTIVIRALS TARGET KEY VIRAL NON-STRUCTURAL PROTEINS NECESSARY FOR HCV REPLICATION
  • Pivotal studies supporting approvals of Zepatier

The $21bn hepatitis C market is expected to undergo a net decline from 2016 as new entrants intensify pricing competition and patient numbers are exhausted from the early 2020s. This report addresses the following questions: - To what extent will the launch of Merck & Co’s Zepatier at a discounted price affect sales of...

  • Antiviral
  • European Union
  • Japan
  • North America
  • United States
  • ANTIVIRAL EFFICACY OF BARACLUDE IN EPIVIR-HBV-REFRACTORY PATIENTS
  • ANTIVIRAL EFFICACY OF HEPSERA IN HBEAG-POSITIVE PATIENTS

Hepatitis B Virus (HBV) Therapeutics - 5EU Drug Forecast and Market Analysis to 2024 Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains...

  • Antiviral
  • World
  • Forecast
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.

(USA) ##.

  • Antiviral
  • Hepatitis
  • United States
  • World
  • Market Shares
  • Brazil: Fastest Growing Therapy Classes (ATC 3)

New drugs are classified into one of the categories described in Table ##, below.

  • Antiviral
  • Pharmaceutical
  • Brazil
  • Demand
  • GlaxoSmithKline plc
  • HIV TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • HIV TREATMENT DRUGS INDUSTRY ASSESSMENTS

ANTIVIRAL THERAPY SUPPRESSES THE REPLICATION OF HIV INFECTION IN THE BODY.

  • Antiviral
  • China
  • Demand
  • Market Size
  • Supply
  • HIV TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • HIV TREATMENT DRUGS INDUSTRY ASSESSMENTS

Antiviral therapy suppresses the replication of HIV infection in the body.

  • Antiviral
  • China
  • Co. Shanghai Boeringer Ingelheim Pharmaceutical Co., Ltd.
  • Ltd. Beijing Sanjiu Wandong Pharmaceutical Co., Ltd.
  • UNAIDS
  • 3.4.2 ANTIVIRAL THERAPY
  • RECOMMENDED ANTIVIRAL REGIMENS FOR THE MANAGEMENT OF GH IN IMMUNOCOMPETENT PATIENTS

Opportunity Analyzer: Genital Herpes - Opportunity Analysis and Forecasts to 2023 Summary Genital herpes (GH) is a life-long viral infection of the genitalia and urogenital tract. It is one of the most common sexually transmitted infections (STIs) and is a leading cause of genital ulcers around the world. Patients...

  • Antiviral
  • Therapy
  • United States
  • Forecast
  • Genocea Biosciences, Inc.
  • 6.3.1 Phase II
  • 3. Hepatitis C - Approved Drugs Sales & Forecast

This study will evaluate the safety, tolerability and antiviral efficacy of Sofosbuvir with Ribavirin (RBV) participants with genotype ## or ## Hepatitis C virus (HCV) infection who have chronic renal insufficiency.

  • Antiviral
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • COMMERCIAL ASSESSMENT - CURRENT & FUTURE PLAYERS

COMMERCIAL ASSESSMENT - CURRENT & FUTURE PLAYERS BRISTOL-MYERS SQUIBB SOLD ITS ANTIVIRAL R& D BUSINESS, INCLUDING HIV PIPELINE ASSETS, TO VIIV HEALTHCARE IN DECEMBER 2015.

  • Antiviral
  • United States
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.
  • ViiV Healthcare Ltd.

Human Immunodeficiency Virus (HIV) - China Drug Forecast and Market Analysis to 2023 ## Table of Contents ## Table of Contents ## ## Introduction ## ##. ## Catalyst ## ##. ## Related Reports ## ##. ## Upcoming Related Reports ## ## Disease Overview ## ##. ## Etiology ## ##. ##. ## Viral Lifecycle ## ##. ##

  • Antiviral
  • Therapy
  • China
  • Demand
  • Forecast

Human Immunodeficiency Virus (HIV) - Japan Drug Forecast and Market Analysis to 2023 ## Table of Contents ## Table of Contents ## ## Introduction ## ##. ## Catalyst ## ##. ## Related Reports ## ##. ## Upcoming Related Reports ## ## Disease Overview ## ##. ## Etiology ## ##. ##. ## Viral Lifecycle ## ##. ##

  • Antiviral
  • HIV AIDS
  • Therapy
  • Japan
  • Demand

Human Immunodeficiency Virus (HIV) - US Drug Forecast and Market Analysis to 2023 ## Table of Contents ## Table of Contents ## ## Introduction ## ##. ## Catalyst ## ##. ## Related Reports ## ##. ## Upcoming Related Reports ## ## Disease Overview ## ##. ## Etiology ## ##. ##. ## Viral Lifecycle ## ##. ## Pa

  • Antiviral
  • Therapy
  • United States
  • Demand
  • Forecast